Episode notes
This week, we’re talking about eye treatments with Oculis CEO, Riad Sherif, we have a conversation about mitochondria, with the CEO of Vandria, Klaus Dugi, and there’s also a short discussion about GoCo Health Innovation City in Gothenburg, Sweden, with Moa Dicksdotter, Partnership and Ecosystem.
Times:
02:35 Vandria
20:03 GoCo Health Innovation City
25:54 Oculis
Looking to the eyes
Oculis is a Swiss ophthalmology company developing topical and biologic treatments for retinal disease and neuro‑ophthalmic conditions. Its pipeline spans diabetic macular oedema, dry eye disease, and optic neuropathies, with a focus on non‑invasive delivery formats that can replace or reduce the need for inj ...
Keywords
biotechbiotechnologycancerophthalmologyeyesSwedenGothenburgOculisVandriaGoCo Health Innovation CitySwitzerland